Firmly grounded in science and collaboration.

We are driven by science and believe innovation requires strong collaboration to execute our vision.

Dscf4411

Restoring immune system balance using engineered regulatory T cells (Tregs)

SonomaBio pursues a strategy to treat—and potentially cure—autoimmune and inflammatory diseases.

Dscf4328 Edit 1 Aspect Ratio 5158 4715

Our approach is being validated in the clinic.

We are evaluating our lead Treg program in clinical trials.

Home Feature Patients Care Partners Scaled Aspect Ratio 2154 1654

Our focus brings hope.

We are focused on curing autoimmune and inflammatory diseases and radically improving the lives of patients with autoimmune and inflammatory diseases.

Istock 1353378620 Aspect Ratio 1714 1414

SonomaBio In The News

Sonomabio Lab 0051 Aspect Ratio 1024 1016

Careers at SonomaBio

We unite our people under a shared commitment to innovation, collaboration, diversity and a sense of belonging, and finding cures for patients.